VanEck Associates’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.9M | Buy |
82,240
+4,478
| +6% | +$2.27M | 0.03% | 312 |
|
|
2025
Q4 | $44M | Buy |
77,762
+6,616
| +9% | +$3.52M | 0.04% | 270 |
|
|
2025
Q3 | $31.8M | Buy |
71,146
+2,881
| +4% | +$1.38M | 0.03% | 281 |
|
|
2025
Q2 | $37.1M | Sell |
68,265
-2,405
| -3% | -$1.26M | 0.04% | 249 |
|
|
2025
Q1 | $35M | Buy |
70,670
+1,135
| +2% | +$628K | 0.05% | 236 |
|
|
2024
Q4 | $36.3M | Sell |
69,535
-88
| -0.1% | -$45.8K | 0.05% | 220 |
|
|
2024
Q3 | $35.7M | Buy |
69,623
+7,430
| +12% | +$3.46M | 0.04% | 218 |
|
|
2024
Q2 | $27.7M | Buy |
62,193
+4,518
| +8% | +$1.8M | 0.04% | 228 |
|
|
2024
Q1 | $23M | Buy |
57,675
+1,162
| +2% | +$439K | 0.03% | 245 |
|
|
2023
Q4 | $19.1M | Buy |
56,513
+3,018
| +6% | +$900K | 0.03% | 256 |
|
|
2023
Q3 | $15.6M | Buy |
53,495
+1,822
| +4% | +$569K | 0.03% | 278 |
|
|
2023
Q2 | $17.7M | Buy |
51,673
+3,573
| +7% | +$1.08M | 0.04% | 266 |
|
|
2023
Q1 | $12.3M | Buy |
48,100
+2,997
| +7% | +$738K | 0.03% | 312 |
|
|
2022
Q4 | $12M | Sell |
45,103
-1,366
| -3% | -$333K | 0.03% | 310 |
|
|
2022
Q3 | $8.71M | Buy |
46,469
+2,665
| +6% | +$572K | 0.03% | 338 |
|
|
2022
Q2 | $8.79M | Sell |
43,804
-137
| -0.3% | -$32.1K | 0.02% | 351 |
|
|
2022
Q1 | $13.3M | Sell |
43,941
-838
| -2% | -$245K | 0.03% | 315 |
|
|
2021
Q4 | $16.1M | Buy |
44,779
+9,145
| +26% | +$3.15M | 0.04% | 285 |
|
|
2021
Q3 | $11.8M | Buy |
35,634
+5,649
| +19% | +$1.9M | 0.03% | 325 |
|
|
2021
Q2 | $9.19M | Buy |
29,985
+3,609
| +14% | +$1.01M | 0.02% | 363 |
|
|
2021
Q1 | $6.5M | Buy |
26,376
+2,103
| +9% | +$529K | 0.02% | 397 |
|
|
2020
Q4 | $6.62M | Buy |
24,273
+759
| +3% | +$188K | 0.02% | 351 |
|
|
2020
Q3 | $5.56M | Buy |
23,514
+2,259
| +11% | +$507K | 0.02% | 342 |
|
|
2020
Q2 | $4.04M | Buy |
21,255
+2,364
| +13% | +$424K | 0.01% | 364 |
|
|
2020
Q1 | $3.12M | Sell |
18,891
-2,130
| -10% | -$390K | 0.02% | 388 |
|
|
2019
Q4 | $4.14M | Buy |
21,021
+13,770
| +190% | +$2.58M | 0.02% | 394 |
|
|
2019
Q3 | $1.3M | Buy |
7,251
+606
| +9% | +$105K | 0.01% | 546 |
|
|
2019
Q2 | $1.16M | Buy |
6,645
+3,168
| +91% | +$543K | 0.01% | 568 |
|
|
2019
Q1 | $661K | Buy |
+3,477
| New | +$618K | ﹤0.01% | 645 |
|
|
2015
Q2 | – | Sell |
-963
| Closed | -$54K | – | 827 |
|
|
2015
Q1 | $54K | Buy |
963
+459
| +91% | +$26K | ﹤0.01% | 687 |
|
|
2014
Q4 | $30K | Buy |
+504
| New | +$28.1K | ﹤0.01% | 696 |
|
|
2014
Q1 | – | Sell |
-636,012
| Closed | -$27.1M | – | 704 |
|
|
2013
Q4 | $27.1M | Buy |
+636,012
| New | +$26.8M | 0.14% | 114 |
|
Other funds holding ISRG
VCM
VPM
VanEck Associates's ISRG Position: Q1 2026 in Review
VanEck Associates increased its Intuitive Surgical (ISRG) stake by 5.8% in Q1 2026, buying an estimated $2.27M and bringing the position to 82,240 shares worth $37.9M. The position accounts for 0.03% of the portfolio, ranked #312.
VanEck Associates first reported a position in ISRG in Q4 2013 and has held it in 32 quarters since. The position peaked at $44M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- VanEck Associates held 82,240 shares of Intuitive Surgical worth $37.9M as of Q1 2026.
- VanEck Associates bought 4,478 Intuitive Surgical shares in Q1 2026, an estimated $2.27M.
- Intuitive Surgical made up 0.03% of VanEck Associates's portfolio in Q1 2026, its #312 holding.
- VanEck Associates first reported a position in Intuitive Surgical in Q4 2013 and has held it in 32 quarters since.
- VanEck Associates's Intuitive Surgical position peaked at $44M in Q4 2025.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.